Diagnosis and treatment of depression in Alzheimer's disease: Impact on mood and cognition

Panminerva Medica

Volumn 49, Issue 3, 2007, Pages 139-149

  Appleby, B S ^a,b   Roy, P ^a   Valenti, A ^a   Lee, H B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Alzheimer disease; Cognition; Depression, diagnosis

Indexed keywords

ANTIDEPRESSANT AGENT;

AFFECT; ALZHEIMER DISEASE; COGNITION; DEPRESSION; HUMAN; QUALITY OF LIFE; REVIEW;

AFFECT; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; COGNITION; DEPRESSION; HUMANS; QUALITY OF LIFE;

EID: 36349010086     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7.
2. Minino AM, Heron MP, Smith BL, Division of Vital Statistics. Deaths: preliminary data for 2004. Statistics Reports NVSS; 2006.p.54.
3. Peden M, McGee K, Krug E, editors. Injury: a leading cause of global burden of disease, 2000. Geneva: World Health Organization; 2002.
4. Caselli RJ, Boeve BF. The degenerative dementias. In: Goetz CG, editor. Textbook of clinical neurology. Philadelphia, Pennsylvania: Saunders; 2003.p.686.
5. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County study on Memory in Aging. Am J Psychiatry 2000;157:708-14.
6. Steinberg M, Sheppard JM, Tschanz JT, Norton MC, Steffens DC, Breitner JC et al. The incidence of mental and behavioral disturbances in dementia: the Cache County study. J Neuropsychiatry Clin Neurosci 2003;15:340-5.
7. Steinberg M, Tschanz JT, Corcoran C, Steffens DC, Norton MC, Lyketsos CG et al. The persistence of neuropsychiatric symptoms in dementia: the Cache County study. Int J Geriatr Psychiatry 2004;19:19-26.
8. Tatsch MF, Bottino CM, Avevedo D, Hototian SR, Moscoso MA, Folquitto JC et al. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity. Am J Geriatr Psychiatry 2006;14:438-45.
9. Peters KR, Rockwood K, Black SE, Bouchard R, Gauthier S, Hogan D et al. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics. Neurology 2006;66:523-8.
10. Lam LC, Leung T, Lui VW, Leung VP, Chiu HF. Association between cognitive function, behavioral syndromes and two-year clinical outcome in Chinese subjects with late-onset Alzheimer's disease. Int Psychogeriatr 2006;18:517-26.
11. Migliorelli R, Teson A, Sabe L, Petracchi M, Leiguarda R, Starkstein S. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry 1995;152:37-44.
12. Bowirrat A, Oscar-Berman M, Logroscino G. Association of depression with Alzheimer's disease and vascular dementia in an elderly Arab population of Wadi-Ara, Israel. Int J Geriatr Psychiatry 2006;21:246-51.
13. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA 2002;2888:1475-83.
14. Liu CY, Fuh JL, Teng EL, Wang SJ, Wang PN, Yang YY et al. Depressive disorders in Chinese patients with Alzheimer's disease. Acta Psychiatr Scand 1999;100:451-5.
15. Landes AM, Sperry SD, Strauss ME. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2005;17:342-9.
16. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry 2005;162:2086-93.
17. Holtzer R, Scarmeas N, Wegesin DJ, Albert M, Brandt J, Dubois B et al. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. JAGS 2005;53:2083-9.
18. Gilley DW, Wilson RS, Bienias JL, Bennett DA, Evans DA. Predictors of depressive symptoms in persons with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci 2004;59:P75-83.
19. Steinberg M, Corcoran C, Tschanz JT, Huber C, Welsh-Bohmer K, Norton MC et al. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 2006;21:824-30.
20. Hollingworth P, Hamshere ML, Moskvina V, Dowzell K, Moore PJ, Foy C et al. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J Am Geriatr Soc 2006;54:1348-54.
21. Cummings JL, Ross W, Absher J, Gornbein J, Hadjiaghai L. Depressive symptoms in Alzheimer's disease: Assessment and determinants. Alzheimer Dis Assoc Disord 1995;9:87-93.
22. Heun R, Kockler M, Ptok U. Depression in Alzheimer's disease: is there a temporal relationship between the onset of depression and the onset of dementia. Eur Psychiatry 2002;17:254-8.
23. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Backmann L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002.
24. Wilkosz PA, Miyahara S, Lopez OL, DeKosky ST, Sweet RA. Prediction of psychosis onset in Alzheimer disease: the role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes. Am J Geriatr Psychiatry 2006;14:352-60.
25. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry 2003;160:857-66.
26. Mizrabi R, Starkstein SE, Jorge R, Robinson RG. Phenomenology and clinical correlates of delusions in Alzheimer disease. Am J Geriatr Psychiatry 2006;14:573-81.
27. Bassiony MM, Warren A, Rosenblatt A, Baker A, Steinberg M, Steele CD et al. The relationship between delusions and depression in Alzheimer's disease. Int J Geriatr Psychiatry 2002;17:549-56.
28. Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 1996;153:1438-43.
29. Butt ZA, Strauss ME. Relationship of family and personal history to the occurrence of depression in persons with Alzheimer's disease. Am J Geriatr Psychiatry 2001;9:249-54.
30. Strauss ME, Ogrocki PK. Confirmation of an association between family history of affective disorder and the depressive syndrome in Alzheimer's disease. Am J Psychiatry 1996;153:1340-2.
31. Garre-Olmo J, Lopez-Pousa J, Vilalta-Franch J, Turon-Estrada A, Hernandez-Ferrandiz M, Lozano-Gallego M et al. Evolution of depressive symptoms in Alzheimer disease: one year follow-up. Alzheimer Dis Assoc Disord 2003;17:77-85.
32. Shin I, Carter M, Masterman D, Fairbanks L, Cummings JL. Neuropsychiatric symptoms and quality of life in Alzheimer's disease. Am J Geriatr Psychiatry 2005;13:469-74.
33. Lam LC, Tam CW, Chiu HF, Lui VW. Depression and apathy affect functioning in community active subjects with questionable dementia and mild Alzheimer's disease. Int J Geriatr Psychiatry 2007;22:431-7.
34. de Ronchi DD, Bellini F, Berardi D, Serretti A, Ferrari B, Dalmonte E. Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education. Am J Geriatr Psychiatry 2005;13:672-85.
35. Potter GG, Steffens DC. Contribution of depression to cognitive impairment and dementia in older adults. Neurologist 2007;13:105-17.
36. Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neurpsychiatry Clin Neurosci 1997;9:556-61.
37. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patient's with Alzheimer's disease. Am J Psychiatry 1990;147:1049-51.
38. Kopetz S, Steele CD, Brandt J, Baker A, Kronberg M, Galik E et al. Characteristics and outcomes of dementia residents in an assisted living facility. Int J Geriatr Psychiatry 2000;15:586-93.
39. Suh GH, Kil YB, Shah A, Lee JY. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes. Int J Geriatr Psychiatry 2005;20:26-34.
40. Rubio A, Vestner AL, Stewart JM, Forbes NT, Conwell Y, Cox C. Suicide and Alzheimer's pathology in the elderly: a case-control study. Biol Psychiatry 2001;49:137-45.
41. Pinquart M, Sorensen S. Differences between caregivers and non-caregivers in psychological health and physical health: a meta-analysis. Psychol Aging 2003;18:250-67.
42. Gallagher D, Rose J Rivera P, Lovett S, Thompson L. Prevalence of depression in family caregivers. Gerontologist 1989;29:449-56.
43. Schulz R, Visintainer P, Williamson GM. Psychiatric and physical morbidity effects of caregiving. J Gerontol 1990;45:P181-91.
44. Hooker K, Monahan DJ, Bowman SR, Frazier LD, Shifren K. Personality counts for a lot: predictors of mental and physical health of spouse caregivers in two disease groups. J Gerontol B Psychol Sci Soc Sci 1998;53:P73-85.
45. Ory M, Hoffman R, Yee J, Tennstedt S, Schulz R. Prevalence and impact of caregiving: a detailed comparison between dementia and non-dementia caregivers. Gerontologist 1999;39:177-85.
46. Neundorfer MM, McClendon MJ, Smyth KA, Stuckey JC, Strauss ME, Patterson MB. A longitudinal study of the relationship between levels of depression among persons with Alzheimer's disease and levels of depression among their family caregivers. J Gerontol B Psychol Sci Soc Sci 2001;56:P301-13.
47. Thomas P, Lalloue F, Preux PM, Hazif-Thomas C, Pariel S, Inscale R. Dementia patients caregivers quality of life: the PIXEL study. Int J of Geriatr Psychiatry 2005;21:50-6.
48. Mittelman M, Haley W, Clay O, Roth D. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology 2006;67:1592-9.
49. Zweig RM, Ross CA, Hedreen JC. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988;24:233-42.
50. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ et al. Neuropathology of aminergic nuclei in Alzheimer's disease. Prog Clin Biol Res 1989;317:353-65.
51. Zubenko GS, Moosy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990;47:209-14.
52. Zubenko GS. Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology 1992;6:77-93.
53. Forstl H, Burns A, Luthert P. Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med 1992;22:877-84.
54. Holmes C, Arranz M, Collier D, Powell J, Lovestone S. Depression in Alzheimer's disease: the effect of serotonin receptor gene variation. Am J Med Genet B Neuropsychiatr Genet 2003;119B:40-3.
55. Garcia-Alloza M, Tsang SW, Gil-Bea FJ, Francis PT, Lai MK, Marcos B et al. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. Neurobiol Aging 2006;27:1110-7.
56. McCully MC, Day IN, Homes C. Association between interleukin 1-® promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2004;124B:50-3.
57. Holthoff V, Beuthlen-Baumann B, Kalbe E, Ludecke S, Lenz O, Zundorf G et al. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry 2005;57:412-21.
58. Lee DY, Choo IH, Jhoo JH, Kim KW, Youn JC, Lee DS et al. Frontal dysfunction underlies depressive syndrome in Alzheimer's disease: A FDG-PET study. Am J Geriatr Psychiatry 2006;14:625-8.
59. Hoogendijk WJ, Meynen G, Endert E, Hofman MA, Swaab DF. Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression. Neurobiol Aging 2006;27:780.e1-780.e2.
60. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP et al. Increased hippocampal plaques and tangles in patients with Alzheimer's disease with a lifetime history of major depression. Arch Gen Psychiatry 2006;63:161-7.
61. Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 2003;61:1102-7.
62. Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL. Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 2006;67:660-5.
63. Wagle AC, Ho LW, Wagle SA, Berrios GE. Psychometric behaviour of BDI in Alzheimer's disease patients with depression. Int J Geriatr Psychiatry 2000;15:63-9.
64. Muller-Thomsen, Arlt S, Mann U, Ma®, Ganzer S. Detecting depression in Alzheimer's disease: evaluation of four different scales. Arch Clin Neuropsychol 2005;20:271-6.
65. Mayer LS, Bay RC, Politis A, Steinberg M, Steele C, Baker AS et al. Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. Int J Geriatr Psychiatry 2006;21:930-6.
66. Vilalta-Franch J, Garre-Olmo J, Lopez-Pousa S, Turon-Estrada A, Lozano-Gallego M, Hernandez-Ferrandiz M et al. Diagnostic criteria for depression in Alzheimer disease. Am J Geriatr Psychiatry 2006;14:589-97.
67. Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am J Geriatr Psychiatry 2002;10:129-41. Erratum in: Am J Geriatr Psychiatry 2002;10:264.
68. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F. The National Depressive and Manic-Depressive Consensus Statement on the undertreatment of depression. JAMA 1997;277:333-40.
69. Chemerinski E, Petracca G, Sabe L, Kremer J, Starkstein SE. The specificity of depressive symptoms in patients with Alzheimer's disease. Am J Psychiatry 2001;158:68-72.
70. Burke W, Roccaforte W, Wengel S, McArthur-Miller D, Folks D, Potter J. Disagreement in the reporting of depressive symptoms between patients with dementia of the alzheimer type and their collateral sources. Am J Geriatr Psychiatry 1998;6:308-19.
71. Feher EP, Mahurin RK, Inbody SB, Crook TH, Pirozzolo FJ. Anosognosia in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1991;4:136-46.
72. Sevush S, Leve N. Denial of memory deficits in Alzheimer's disease. Am J Psychiatry 1993;150:748-51.
73. Rosenberg P, Mielke M, Lyketsos C. Caregiver assessment of patients' depression in Alzheimer disease: a longitudinal analysis in a drug treatment study. Am J Geriatr Psychiatry 2005;13:822-6.
74. Starkstein SE, Mizrabi R, Garau L. Specificity of symptoms of depression in Alzheimer disease: a longitudinal analysis. Am J Geriatr Psychiatry 2005;13:802-7.
75. Olazaran J, Muniz R, Reisberg B, Pena-Casanova J, del Ser T, Cruz-Jentoft AJ et al. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology 2004;63:2348-53.
76. Regan C, Katona C, Walker Z, Livingston G. Relationship of exercise and other risk factors to depression of Alzheimer's disease: the LASER-AD study. Int J Geriatr Psychiatry 2005;20:261-8.
77. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 2003;290:2015-22.
78. Logsdon RG, Teri L. The Pleasant Events Schedule-AD: psychometric properties and relationship to depression and cognition in Alzheimer's disease patients. Gerontologist 1997;37:40-5.
79. Teri L, Logsdon RG, McCurry SM. Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am 2002;86:641-56, viii.
80. Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E et al. Double-blind trial of Imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989;146:45-9.
81. Petracca G, Teson A, Chemerinski E, Leiguarda R, Starkstein SE. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1996;8:270-5.
82. Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry 1996;168:149-57.
83. Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C et al. Treating depression in Alzheimer disease. Arch Gen Psychiatry 2003;60:737-46.
84. Magai C, Kennedy G, Cohen CI, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am J Geriatr Psychiatry 8:66-74.
85. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M. A controlled multicenter clinical study of Citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992;86:138-45.
86. Nyth AL, Gottfries CG. The clinical efficacy of Citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990;157:894-901.
87. Petracca GM, Chemerinski E, Starkstein SE. A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Int Psychogeriatr 2001;13:233-40.
88. Lyketsos CG, Sheppard JE, Steele CD, Kopunek S, Steinberg M, Baker AS et al. Randomized placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the depression in Alzheimer 's disease study. Am J Psychiatry 2000;157:1686-9.
89. Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E. Double-blind, randomized, fixed dose trial of fluoxetine versus amitriptyline in the treatment of major depression complicating Alzheimer's disease. Psychosomatics 1997;38:246-52.
90. Katona CL, Hunter BN, Bray J. A double-blind comparison of the efficacy and safely of paroxetine and Imipramine in the treatment of depression with dementia. Int J Geriatr Psychiatry 1998;13:100-8.
91. Sobow TM, Maczkiewicz M, Kloszewska I. Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease. Int J Geriatr Psychiatry 2001;16:1107-9.
92. Rao V, Spiro JR, Rosenberg PB, Lee HB, Rosenblatt A, Lyketsos CG. An open-label study of escitalopram (Lexapro®) for the treatment of 'depression of Alzheimer's disease (dAD). Int J Geriatr Psychiatry 2006;21:273-4.
93. Mizukami K, Tanaka Y, Asada T Efficacy of milnacipran on the depressive state in patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1342-6.
94. Raji MA, Brady SR. Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother 2001;35:1024-7.
95. Steinberg M, Munro CA, Samus Q, Rabins, PV, Brandt J, Lyketsos CG. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study. Int J Geriatr Psychiatry 2004;19:144-50.
96. Westenberg HG, Sandner C. Tolerability and safety of fluvoxamine and other antidepressants. Int J Clin Pract 2006;60:482-91.
97. Stoppe A, Louza M, Rosa M, Gil G, Rigonatti S. Fixed high-dosed electroconvulsive therapy in the elderly with depression: a double-blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. J ECT 2006;22:92-9.
98. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry 2001;16:919-20.
99. Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K et al. Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry 2006;67:1171-8.
100. Sjogren MJ, Hellstrom PT, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J Clin Psychiatry 2002;63:972-80.
101. Berney A, Vingerhoets F, Perrin A, Guex P, Villemure JG, Burkhard PR et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002;59:1427-9.
102. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:834-9.
103. Takeshita S, Kurisu K, Trop L, Arita K, Akimitsu T, Verhoeff NP et al. Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems. Neurosurg Rev 2005;28:179-86.
104. Okun M, Green J, Saben R, Gross R, Foote KD, Vitek JL. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J Neurol Neurosurg Psychiatry 2003;74:1584-6.
105. Cotelli M, Manenti R, Cappa SF, Geroldi C, Zanetti O, Rossini PM et al. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol 2006;63:1602-4.
106. Sweeney JA, Kmiec JA, Kupfer DJ. Neuropsychological impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 2000;48: 74-84.
107. Powlishta KK, Storandt M, Mandernach TA, Hogan E, Grant EA, Morris JC. Absence of effect of depression on cognitive performance in early-stage Alzheimer Disease. Arch Neurol 2004;61:1265-8.
108. Lopez OL, Boller F, Becker JT, Miller M, Reynolds CF. Alzheimer's disease and depression: neuropsychological impairment and progression of the illness. Am J Psychiatry 1990;147:855-60.
109. Milwain EJ, Nagy Z. Depressive symptoms increase the likelihood of cognitive impairment in elderly people with subclinical Alzheimer pathology. Dement Geriatr Cogn Disord 2005;19:46-50.
110. Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type. Arch Neurol 2004;61:1290-3.
111. Mowla A, Mosavinasah M, Pani A. Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol 2007; 27:67-70.
112. Munro CA, Brandt J, Sheppard JE, Steele CD, Samus QM, Steinberg M et al. Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS). Am J Geriatr Psychiatry 2004;12:491-8.
113. Caballero J, Hitchcock M, Beversdorf D, Scharre D, Nahata M. Long-term effects of antidepressants on cognition in patients with Alzheimer's disease. J Clin Pharm Ther 2006;31:593-8.
114. Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 2004;19:9-18.
115. Teri L, Reifler BV, Veith RC, Barnes R, White E, McLean P et al. Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition. J Gerontol 1991;46:P372-7.